Cite
HARVARD Citation
Kwatra, M. et al. (n.d.). CSIG-26. HETEROGENEITY OF EGFRvIII-POSITIVE GLIOBLASTOMA STEM CELLS: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT. Neuro-oncology. 19 (11), p. vi55. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kwatra, M. et al. (n.d.). CSIG-26. HETEROGENEITY OF EGFRvIII-POSITIVE GLIOBLASTOMA STEM CELLS: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT. Neuro-oncology. 19 (11), p. vi55. [Online].